| Source Date | Board Meeting Date | Details |
|
14-Feb-2024
|
21-Feb-2024
|
Quarterly Results (Revised)
|
|
07-Feb-2024
|
14-Feb-2024
|
Quarterly Results
|
|
01-Nov-2023
|
09-Nov-2023
|
Quarterly Results
|
|
03-Aug-2023
|
14-Aug-2023
|
Quarterly Results
|
|
17-May-2023
|
30-May-2023
|
Audited Results
|
|
07-Feb-2023
|
14-Feb-2023
|
Quarterly Results
|
|
07-Nov-2022
|
14-Nov-2022
|
Quarterly Results Inter alia, to consider and approve to create, issue and or allot equity shares, convertible securities of any other description or warrants or debt securities, through Private Placement / Preferential Issue / Qualified Institutions Placement or such other methods or combinations thereof as may be decided by the Board, subject to such statutory/ regulatory approvals as may be necessary, including the approval of the Shareholders of the Company, wherever required
|
|
04-Aug-2022
|
10-Aug-2022
|
Quarterly Results Inter alia, to consider 1. Subject to the approval of the shareholders an issuance of securities on preferential basis against settlement of due of the subsidiary company of the Company. 2. Any other business matter, if required with the permission of the Chair.
|
|
01-Jun-2022
|
03-Jun-2022
|
Inter-alia, to consider the proposal for issue of one or more of instruments comprising of equity shares, convertible securities of any other description or warrants or debt securities, through Private Placement / Preferential Issue / Qualified Institutions Placement or such other methods or combinations thereof as may be decided by the Board, subject to such statutory/ regulatory approvals as may be necessary, including the approval of the Shareholders of the Company, wherever required.
|
|
23-May-2022
|
30-May-2022
|
Audited Results & Inter alia, 2. Subject to the approval of the shareholders an issuance of securities on preferential basis against settlement of due of the subsidiary company of the Company.
|